Articles

About Authors
Ajinath Kale, Anil Bhanudas Gaikwad*
Laboratory of Molecular Pharmacology, Department of Pharmacy,
Birla Institute of Technology and Science Pilani,
Pilani Campus, Rajasthan, India.
*anil.gaikwad@pilani.bits-pilani.ac.in

Avdesh Thassu
MPharm (Nat. Chem.); MBA(Mkt.)
Associate Vice President
Global Regulatory Affairs,
Emami Limited
athassu@hotmail.com

About Authors
¹AGARWAL POONAM*, ²RATHORE KAMAL SINGH, VIJAY KAVITA^2
1Department of Pharmaceutics, Bhupal Nobles’ College of Pharmacy Udaipur, Rajasthan,
²Faculty, Jaipur, College of Pharmacy, Jaipur India, 313001.
Email : charmiagarwal823@gmail.com

About Authors
Avdesh Thassu
MPharm (Nat. Chem.); MBA(Mkt.)
Associate Vice President
Global Regulatory Affairs,
Emami Limited,
7044455199
athassu@hotmail.com

Chandra Mohan Nandi
MSc. (Organic Chem.)
Deputy Manager,
Global Regulatory Affairs,
Emami Limited,
9051706947
chandramohannandi@yahoo.in

Look back of growth drive for Indian pharmaceutical industry after 75 years of independence and future roadmap.

About Authors
Avdesh Thassu
MPharm (Nat. Chem.); MBA(Mkt.)
Associate Vice President

Historical Overview of Pharmaceutical Industries and Regulatory Affairs:During 1950s, multiple tragedies i.e., sulfanilamide elixir, vaccine tragedy and thalidomide tragedy have resulted in substantial increase of legislations for drug products quality, safety and efficacy. This has also resulted into stricter norms for Marketing Authorization (MA) and Good Manufacturing Practices (GMPs).

About Authors
Ms. Priti B. Savant,Ms. Ashwini R. Pawar, Ms. Kaufiya D. Sayyed , Ms. Pooja R. Yelmar
1,2,3,4 Sahyadri College of Pharmacy Methwade Tal, Sangola, Distsolapur  Maharashtra 413307

About Authors
Avdesh Thassu,^1* Chandra Mohan Nandi ^2
1Associate Vice President
Global Regulatory Affairs,
Emami Limited, India
² Deputy Manager,
Global Regulatory Affairs, Emami Limited, India
*athassu@hotmail.com